Candidate Genes Encoding Dopamine Receptors as Predictors of the Risk of Antipsychotic-Induced Parkinsonism and Tardive Dyskinesia in Schizophrenic Patients

(1) Introduction: Extrapyramidal disorders form the so-called extrapyramidal syndrome (EPS), which is characterized by the occurrence of motor disorders as a result of damage to the basal ganglia and the subcortical-thalamic connections. Often, this syndrome develops while taking medications, in par...

Full description

Bibliographic Details
Main Authors: Elena E. Vaiman, Natalia A. Shnayder, Maxim A. Novitsky, Vera S. Dobrodeeva, Polina S. Goncharova, Elena N. Bochanova, Margarita R. Sapronova, Tatiana E. Popova, Alexey A. Tappakhov, Regina F. Nasyrova
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Biomedicines
Subjects:
Online Access:https://www.mdpi.com/2227-9059/9/8/879
_version_ 1797524616804040704
author Elena E. Vaiman
Natalia A. Shnayder
Maxim A. Novitsky
Vera S. Dobrodeeva
Polina S. Goncharova
Elena N. Bochanova
Margarita R. Sapronova
Tatiana E. Popova
Alexey A. Tappakhov
Regina F. Nasyrova
author_facet Elena E. Vaiman
Natalia A. Shnayder
Maxim A. Novitsky
Vera S. Dobrodeeva
Polina S. Goncharova
Elena N. Bochanova
Margarita R. Sapronova
Tatiana E. Popova
Alexey A. Tappakhov
Regina F. Nasyrova
author_sort Elena E. Vaiman
collection DOAJ
description (1) Introduction: Extrapyramidal disorders form the so-called extrapyramidal syndrome (EPS), which is characterized by the occurrence of motor disorders as a result of damage to the basal ganglia and the subcortical-thalamic connections. Often, this syndrome develops while taking medications, in particular antipsychotics (APs). (2) Purpose: To review studies of candidate genes encoding dopamine receptors as genetic predictors of development of AP-induced parkinsonism (AIP) and AP-induced tardive dyskinesia (AITD) in patients with schizophrenia. (3) Materials and Methods: A search was carried out for publications of PubMed, Web of Science, Springer, and e-Library databases by keywords and their combinations over the last 10 years. In addition, the review includes earlier publications of historical interest. Despite extensive searches of these commonly used databases and search terms, it cannot be ruled out that some publications were possibly missed. (4) Results: The review considers candidate genes encoding dopamine receptors involved in pharmacodynamics, including genes <i>DRD1</i>, <i>DRD2</i>, <i>DRD3</i>, and <i>DRD4</i>. We analyzed 18 genome-wide studies examining 37 genetic variations, including single nucleotide variants (SNVs)/polymorphisms of four candidate genes involved in the development of AIP and AITD in patients with schizophrenia. Among such a set of obtained results, only 14 positive associations were revealed: rs1799732 (141CIns/Del), rs1800497 (C/T), rs6275 (C/T), rs6275 (C/T) <i>DRD2</i>; rs167771 (G/A) <i>DRD3</i> with AIP and rs4532 (A/G) <i>DRD1</i>, rs6277 (C/T), rs6275 (C/T), rs1800497 (C/T), rs1079597 (A/G), rs1799732 (141CIns/Del), rs1045280 (C/G) <i>DRD2</i>, rs6280 (C/T), rs905568 (C/G) <i>DRD3</i> with AITD. However, at present, it should be recognized that there is no final or unique decision on the leading role of any particular SNVs/polymorphisms in the development of AIP and AITD. (5) Conclusion: Disclosure of genetic predictors of the development of AIP and AITD, as the most common neurological adverse drug reactions (ADRs) in the treatment of patients with psychiatric disorders, may provide a key to the development of a strategy for personalized prevention and treatment of the considered complication of AP therapy for schizophrenia in real clinical practice.
first_indexed 2024-03-10T08:59:03Z
format Article
id doaj.art-049781738574494c9ea1dc5d15b3deef
institution Directory Open Access Journal
issn 2227-9059
language English
last_indexed 2024-03-10T08:59:03Z
publishDate 2021-07-01
publisher MDPI AG
record_format Article
series Biomedicines
spelling doaj.art-049781738574494c9ea1dc5d15b3deef2023-11-22T06:51:25ZengMDPI AGBiomedicines2227-90592021-07-019887910.3390/biomedicines9080879Candidate Genes Encoding Dopamine Receptors as Predictors of the Risk of Antipsychotic-Induced Parkinsonism and Tardive Dyskinesia in Schizophrenic PatientsElena E. Vaiman0Natalia A. Shnayder1Maxim A. Novitsky2Vera S. Dobrodeeva3Polina S. Goncharova4Elena N. Bochanova5Margarita R. Sapronova6Tatiana E. Popova7Alexey A. Tappakhov8Regina F. Nasyrova9Centre of Personalized Psychiatry and Neurology, V.M. Bekhterev National Medical Research Centre for Psychiatry and Neurology, 192019 Saint-Petersburg, RussiaCentre of Personalized Psychiatry and Neurology, V.M. Bekhterev National Medical Research Centre for Psychiatry and Neurology, 192019 Saint-Petersburg, RussiaCentre of Personalized Psychiatry and Neurology, V.M. Bekhterev National Medical Research Centre for Psychiatry and Neurology, 192019 Saint-Petersburg, RussiaCentre of Personalized Psychiatry and Neurology, V.M. Bekhterev National Medical Research Centre for Psychiatry and Neurology, 192019 Saint-Petersburg, RussiaCentre of Personalized Psychiatry and Neurology, V.M. Bekhterev National Medical Research Centre for Psychiatry and Neurology, 192019 Saint-Petersburg, RussiaDepartment of Pharmacology and Pharmaceutical Consulting, V.F. Voino-Yasenetsky Krasnoyarsk State Medical University, 660022 Krasnoyarsk, RussiaDepartment of Medical Genetics and Clinical Neurophysiology, Institute of Postgraduate Education, V.F. Voino-Yasenetsky Krasnoyarsk State Medical University, 660022 Krasnoyarsk, RussiaYakutsk Scientific Center for Complex Medical Problems, Department of Epidemiology of Chronic Non-Inflectional Diseases, 677018 Yakutsk, RussiaDepartment of Neurology and Psychiatry, Medical Institute, M.K. Ammosov North-Eastern Federal University, 677000 Yakutsk, RussiaCentre of Personalized Psychiatry and Neurology, V.M. Bekhterev National Medical Research Centre for Psychiatry and Neurology, 192019 Saint-Petersburg, Russia(1) Introduction: Extrapyramidal disorders form the so-called extrapyramidal syndrome (EPS), which is characterized by the occurrence of motor disorders as a result of damage to the basal ganglia and the subcortical-thalamic connections. Often, this syndrome develops while taking medications, in particular antipsychotics (APs). (2) Purpose: To review studies of candidate genes encoding dopamine receptors as genetic predictors of development of AP-induced parkinsonism (AIP) and AP-induced tardive dyskinesia (AITD) in patients with schizophrenia. (3) Materials and Methods: A search was carried out for publications of PubMed, Web of Science, Springer, and e-Library databases by keywords and their combinations over the last 10 years. In addition, the review includes earlier publications of historical interest. Despite extensive searches of these commonly used databases and search terms, it cannot be ruled out that some publications were possibly missed. (4) Results: The review considers candidate genes encoding dopamine receptors involved in pharmacodynamics, including genes <i>DRD1</i>, <i>DRD2</i>, <i>DRD3</i>, and <i>DRD4</i>. We analyzed 18 genome-wide studies examining 37 genetic variations, including single nucleotide variants (SNVs)/polymorphisms of four candidate genes involved in the development of AIP and AITD in patients with schizophrenia. Among such a set of obtained results, only 14 positive associations were revealed: rs1799732 (141CIns/Del), rs1800497 (C/T), rs6275 (C/T), rs6275 (C/T) <i>DRD2</i>; rs167771 (G/A) <i>DRD3</i> with AIP and rs4532 (A/G) <i>DRD1</i>, rs6277 (C/T), rs6275 (C/T), rs1800497 (C/T), rs1079597 (A/G), rs1799732 (141CIns/Del), rs1045280 (C/G) <i>DRD2</i>, rs6280 (C/T), rs905568 (C/G) <i>DRD3</i> with AITD. However, at present, it should be recognized that there is no final or unique decision on the leading role of any particular SNVs/polymorphisms in the development of AIP and AITD. (5) Conclusion: Disclosure of genetic predictors of the development of AIP and AITD, as the most common neurological adverse drug reactions (ADRs) in the treatment of patients with psychiatric disorders, may provide a key to the development of a strategy for personalized prevention and treatment of the considered complication of AP therapy for schizophrenia in real clinical practice.https://www.mdpi.com/2227-9059/9/8/879extrapyramidal syndromeantipsychoticsadverse drug reactionantipsychotic-induced parkinsonismantipsychotic-induced tardive dyskinesiagenetics
spellingShingle Elena E. Vaiman
Natalia A. Shnayder
Maxim A. Novitsky
Vera S. Dobrodeeva
Polina S. Goncharova
Elena N. Bochanova
Margarita R. Sapronova
Tatiana E. Popova
Alexey A. Tappakhov
Regina F. Nasyrova
Candidate Genes Encoding Dopamine Receptors as Predictors of the Risk of Antipsychotic-Induced Parkinsonism and Tardive Dyskinesia in Schizophrenic Patients
Biomedicines
extrapyramidal syndrome
antipsychotics
adverse drug reaction
antipsychotic-induced parkinsonism
antipsychotic-induced tardive dyskinesia
genetics
title Candidate Genes Encoding Dopamine Receptors as Predictors of the Risk of Antipsychotic-Induced Parkinsonism and Tardive Dyskinesia in Schizophrenic Patients
title_full Candidate Genes Encoding Dopamine Receptors as Predictors of the Risk of Antipsychotic-Induced Parkinsonism and Tardive Dyskinesia in Schizophrenic Patients
title_fullStr Candidate Genes Encoding Dopamine Receptors as Predictors of the Risk of Antipsychotic-Induced Parkinsonism and Tardive Dyskinesia in Schizophrenic Patients
title_full_unstemmed Candidate Genes Encoding Dopamine Receptors as Predictors of the Risk of Antipsychotic-Induced Parkinsonism and Tardive Dyskinesia in Schizophrenic Patients
title_short Candidate Genes Encoding Dopamine Receptors as Predictors of the Risk of Antipsychotic-Induced Parkinsonism and Tardive Dyskinesia in Schizophrenic Patients
title_sort candidate genes encoding dopamine receptors as predictors of the risk of antipsychotic induced parkinsonism and tardive dyskinesia in schizophrenic patients
topic extrapyramidal syndrome
antipsychotics
adverse drug reaction
antipsychotic-induced parkinsonism
antipsychotic-induced tardive dyskinesia
genetics
url https://www.mdpi.com/2227-9059/9/8/879
work_keys_str_mv AT elenaevaiman candidategenesencodingdopaminereceptorsaspredictorsoftheriskofantipsychoticinducedparkinsonismandtardivedyskinesiainschizophrenicpatients
AT nataliaashnayder candidategenesencodingdopaminereceptorsaspredictorsoftheriskofantipsychoticinducedparkinsonismandtardivedyskinesiainschizophrenicpatients
AT maximanovitsky candidategenesencodingdopaminereceptorsaspredictorsoftheriskofantipsychoticinducedparkinsonismandtardivedyskinesiainschizophrenicpatients
AT verasdobrodeeva candidategenesencodingdopaminereceptorsaspredictorsoftheriskofantipsychoticinducedparkinsonismandtardivedyskinesiainschizophrenicpatients
AT polinasgoncharova candidategenesencodingdopaminereceptorsaspredictorsoftheriskofantipsychoticinducedparkinsonismandtardivedyskinesiainschizophrenicpatients
AT elenanbochanova candidategenesencodingdopaminereceptorsaspredictorsoftheriskofantipsychoticinducedparkinsonismandtardivedyskinesiainschizophrenicpatients
AT margaritarsapronova candidategenesencodingdopaminereceptorsaspredictorsoftheriskofantipsychoticinducedparkinsonismandtardivedyskinesiainschizophrenicpatients
AT tatianaepopova candidategenesencodingdopaminereceptorsaspredictorsoftheriskofantipsychoticinducedparkinsonismandtardivedyskinesiainschizophrenicpatients
AT alexeyatappakhov candidategenesencodingdopaminereceptorsaspredictorsoftheriskofantipsychoticinducedparkinsonismandtardivedyskinesiainschizophrenicpatients
AT reginafnasyrova candidategenesencodingdopaminereceptorsaspredictorsoftheriskofantipsychoticinducedparkinsonismandtardivedyskinesiainschizophrenicpatients